{"id":"https://openalex.org/W2006459305","doi":"https://doi.org/10.7164/antibiotics.49.155","title":"Inhibition of Mouse Tumor Metastasis with Nojirimycin-related Compounds.","display_name":"Inhibition of Mouse Tumor Metastasis with Nojirimycin-related Compounds.","publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W2006459305","doi":"https://doi.org/10.7164/antibiotics.49.155","mag":"2006459305","pmid":"https://pubmed.ncbi.nlm.nih.gov/8621356"},"language":"en","primary_location":{"id":"doi:10.7164/antibiotics.49.155","doi":"https://doi.org/10.7164/antibiotics.49.155","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.49.155","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/49/2/49_2_155/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/49/2/49_2_155/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033069282","display_name":"Tsutomu Tsuruoka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405275510","display_name":"Meiji Seika Pharma Co., Ltd. (Japan)","ror":"https://ror.org/03qt4xn36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405275510"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"TSUTOMU TSURUOKA","raw_affiliation_strings":["Meiji Seika Kaisha, Ltd., Yokohama, Japan","Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd","Present address: Medical Research Department, Pharmaceutical Division, Meiji Seika Kaisha, Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Meiji Seika Kaisha, Ltd., Yokohama, Japan","institution_ids":["https://openalex.org/I4405275510"]},{"raw_affiliation_string":"Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd","institution_ids":["https://openalex.org/I4405275510"]},{"raw_affiliation_string":"Present address: Medical Research Department, Pharmaceutical Division, Meiji Seika Kaisha, Ltd","institution_ids":["https://openalex.org/I4405275510"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025862209","display_name":"HARUMI FUKUYASU","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405275510","display_name":"Meiji Seika Pharma Co., Ltd. (Japan)","ror":"https://ror.org/03qt4xn36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405275510"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"HARUMI FUKUYASU","raw_affiliation_strings":["Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd","institution_ids":["https://openalex.org/I4405275510"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020642457","display_name":"MIYUKI ISHII","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405275510","display_name":"Meiji Seika Pharma Co., Ltd. (Japan)","ror":"https://ror.org/03qt4xn36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405275510"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"MIYUKI ISHII","raw_affiliation_strings":["Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd","institution_ids":["https://openalex.org/I4405275510"]}]},{"author_position":"middle","author":{"id":null,"display_name":"TAKAYUKI USUI","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405275510","display_name":"Meiji Seika Pharma Co., Ltd. (Japan)","ror":"https://ror.org/03qt4xn36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405275510"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"TAKAYUKI USUI","raw_affiliation_strings":["Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd","institution_ids":["https://openalex.org/I4405275510"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112446147","display_name":"Seiji Shibahara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405275510","display_name":"Meiji Seika Pharma Co., Ltd. (Japan)","ror":"https://ror.org/03qt4xn36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405275510"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"SEIJI SHiBAHARA","raw_affiliation_strings":["Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd","Present address: Product development Department, Pharmaceutical Division, Meiji Seika Kaisha, Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd","institution_ids":["https://openalex.org/I4405275510"]},{"raw_affiliation_string":"Present address: Product development Department, Pharmaceutical Division, Meiji Seika Kaisha, Ltd","institution_ids":["https://openalex.org/I4405275510"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103638098","display_name":"Shigeharu Inouye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405275510","display_name":"Meiji Seika Pharma Co., Ltd. (Japan)","ror":"https://ror.org/03qt4xn36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405275510"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"SHIGEHARU INOUYE","raw_affiliation_strings":["Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd","institution_ids":["https://openalex.org/I4405275510"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405275510"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":2.841,"has_fulltext":true,"cited_by_count":66,"citation_normalized_percentile":{"value":0.89720269,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"49","issue":"2","first_page":"155","last_page":"161"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.9384999871253967,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.9384999871253967,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","score":0.03840000182390213,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nojirimycin","display_name":"nojirimycin","score":0.9399999976158142},{"id":"https://openalex.org/keywords/antimetastatic-activity","display_name":"antimetastatic activity","score":0.8629999756813049},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.8149999976158142},{"id":"https://openalex.org/keywords/b16-melanoma","display_name":"B16 melanoma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/alpha-glucosidase-inhibition","display_name":"\u03b1-glucosidase inhibition","score":0.8820000290870667},{"id":"https://openalex.org/keywords/beta-glucosidase-inhibition","display_name":"\u03b2-glucosidase inhibition","score":0.9869999885559082},{"id":"https://openalex.org/keywords/beta-glucuronidase-inhibition","display_name":"\u03b2-glucuronidase inhibition","score":0.9950000047683716}],"concepts":[{"id":"https://openalex.org/C2776131168","wikidata":"https://www.wikidata.org/wiki/Q251124","display_name":"Lactam","level":2,"score":0.6129865646362305},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5866974592208862},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.518031895160675},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.4996824264526367},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.43596649169921875},{"id":"https://openalex.org/C111771559","wikidata":"https://www.wikidata.org/wiki/Q66295","display_name":"Derivative (finance)","level":2,"score":0.4194435775279999},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.38380956649780273},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21608921885490417},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19166210293769836},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.1889362633228302},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14882448315620422},{"id":"https://openalex.org/C106159729","wikidata":"https://www.wikidata.org/wiki/Q2294553","display_name":"Financial economics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005944","descriptor_name":"Glucosamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005944","descriptor_name":"Glucosamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005944","descriptor_name":"Glucosamine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005966","descriptor_name":"Glucuronidase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D006026","descriptor_name":"Glycoside Hydrolases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D008546","descriptor_name":"Melanoma, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017485","descriptor_name":"1-Deoxynojirimycin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.7164/antibiotics.49.155","doi":"https://doi.org/10.7164/antibiotics.49.155","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.49.155","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/49/2/49_2_155/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},{"id":"pmid:8621356","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8621356","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antibiotics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7164/antibiotics.49.155","doi":"https://doi.org/10.7164/antibiotics.49.155","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.49.155","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/49/2/49_2_155/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2006459305.pdf","grobid_xml":"https://content.openalex.org/works/W2006459305.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1592040753","https://openalex.org/W1920731027","https://openalex.org/W1975253816","https://openalex.org/W1979635562","https://openalex.org/W2010433459","https://openalex.org/W2052218939","https://openalex.org/W2064723291","https://openalex.org/W2066472801","https://openalex.org/W2071160364","https://openalex.org/W2074728422","https://openalex.org/W2081750622","https://openalex.org/W2085876735","https://openalex.org/W2116068036","https://openalex.org/W2124599706","https://openalex.org/W2316678744","https://openalex.org/W2950577552"],"related_works":["https://openalex.org/W3035251333","https://openalex.org/W2316678744","https://openalex.org/W3025829748","https://openalex.org/W2053379628","https://openalex.org/W1986852535","https://openalex.org/W4381951094","https://openalex.org/W2034273491","https://openalex.org/W2313669862","https://openalex.org/W2071160364","https://openalex.org/W3000436956"],"abstract_inverted_index":{"The":[0],"antimetastatic":[1,40,99,110],"activity":[2],"of":[3,18,32,84,91],"ten":[4],"compounds":[5],"structurally":[6],"related":[7,69],"to":[8,70,106],"nojirimycin":[9,33,44,92],"A":[10],"was":[11,104],"examined":[12],"using":[13],"a":[14,88],"pulmonary":[15],"metastatic":[16],"model":[17],"mouse":[19],"B16":[20],"melanoma.":[21],"Nojirimycin":[22,42],"B,":[23,45],"deoxynojirimycin,":[24],"D-gluco-delta-lactam,":[25],"CP3068":[26,61],"and":[27,35,47,58,62,80,94,111,115,119,129],"CP3069":[28,63],"are":[29,82],"structural":[30],"analogues":[31,83],"A,":[34,43,93],"showed":[36,49,72,95,117,131],"potent":[37,50,96,118],"or":[38,51,97,133],"moderate":[39,52,98,120],"activities.":[41,75,100,113,135],"deoxynojirimycin":[46],"D-gluco-delta-lactam":[48,71],"inhibitory":[53,74,121],"activities":[54,122],"against":[55,123],"alpha-glucosidase,":[56],"beta-glucosidase":[57],"beta-mannosidase,":[59],"but":[60,126],"in":[64],"which":[65],"the":[66],"structures":[67],"were":[68],"no":[73,102,134],"CP3041,":[76],"CP3042,":[77],"CP3043,":[78,127],"CP3045":[79,128],"CP3048":[81,130],"sodium":[85],"D-glucaro-delta-lactam":[86],"(ND2001),":[87],"carboxy":[89],"derivative":[90],"But":[101],"analogue":[103],"superior":[105],"ND2001":[107],"concerning":[108],"with":[109],"anti-beta-glucuronidase":[112],"CP3041":[114],"CP3042":[116],"beta-glucuronidase,":[124],"respectively,":[125],"little":[132]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}